19.11.2025 From Europe to the World: Insights from Peter Horby An interview with Peter Horby about Ecraid’s unique clinical trial infrastructure, and the opportunities and challenges ahead. …
13.11.2025 Benefits of group sequential design and sample size re-estimation for randomised controlled trials evaluating the prevention of ventilator-associated pneumonia: a simulation study informed by real world data
12.11.2025 Lennie Derde Appointed New Ecraid Chief Executive Officer Ecraid is pleased to announce the appointment of Lennie Derde as its new Chief Executive Officer.
3.11.2025 How to conduct an individual participant data meta-analysis in response to an emerging pathogen: Lessons learned from Zika and COVID-19 Methodological guidance and recommendations for conducting IPD-MAs, drawing lessons from recent responses to pathogens.
30.10.2025 Ecraid’s Response to the WHO GLASS AMR Crisis Operationalising Europe's coordinated defence against AMR and emerging infectious diseases
